-
Published:
Monday, February 06, 2012
Pharmaceutical company sales and marketing data has never been close to the league of quality of the Business-to-Consumer (B2C)...
-
Published:
Monday, January 09, 2012
A lot of attention is currently on the larger emerging markets that have significantly more growth than the mature markets. The...
-
Published:
Monday, December 05, 2011
Most therapeutic markets in the Pharmaceutical Industry are already becoming crowded (and some even saturated), and yet more co...
-
Published:
Monday, December 05, 2011
In Part 1 of this article we examined some of the barriers to doing business in China that our Clients have found. These includ...
-
Published:
Thursday, November 24, 2011
On the face of it, marketing Oncology drugs is a highly lucrative business for the Pharmaceutical industry.
Therefore, the op...
-
Published:
Thursday, November 24, 2011
There are numerous barriers to growing your brand(s) in China, and not all are easy to overcome. Nonetheless, there is also vas...
-
Published:
Friday, October 14, 2011
No matter how much you plan ahead, new drug development is inherently risky in today’s environment. The potential to spend a la...
-
Published:
Thursday, September 01, 2011
The Oncology market is changing and becoming more competitive than ever before. To succeed in this changing environment, compan...
-
Published:
Saturday, May 14, 2011
Are you noticing that you are suffering from data overload? The Pharmaceutical Industry has a lot of data but much of it, altho...
-
Published:
Thursday, April 14, 2011
Patient-centric marketing sometimes feels like the new ‘buzz word’ as we are hearing this term everywhere these days, but what ...